GlassScriptPhysician profile
Manuel A Melo Bicchi
NPI 1154748036
$1,181.58
in general payments reported to CMS, 2019-2025
20 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $85.88 · 2021: $174 · 2022: $70.72 · 2023: $173 · 2024: $265 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $193.45 | 2023-2025 | Vyepti |
| Tanabe Pharma America, INC. | $148.78 | 2023-2025 | Radicava |
| Emd Serono, INC. | $124.16 | 2019 | |
| Neuropace, INC. | $112.28 | 2019-2020 | |
| Sk Life Science, INC. | $87.50 | 2021-2022 | |
| Greenwich Biosciences, INC. | $66.35 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $63.80 | 2023-2024 | Hyqvia |
| Ucb, INC. | $58.80 | 2022-2023 | Fintepla |
| Neurelis, INC. | $50.55 | 2021 | |
| Boston Scientific Corporation | $48.21 | 2023 | Watchman Flx |
| Medtronic USA, INC. | $39.24 | 2019-2020 | |
| Pfizer INC. | $34.35 | 2025 | |
| Genentech USA, INC. | $27.06 | 2025 | Ocrevus Zunovo |
| Amgen INC. | $24.91 | 2025 | Uplizna |
| Jazz Pharmaceuticals INC. | $22.24 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $21.14 | 2019 | |
| Microtransponder, INC. | $18.26 | 2025 | |
| Celgene Corporation | $14.84 | 2025 | Zeposia |
| Abbvie INC. | $13.84 | 2024 | |
| Lilly USA, LLC | $11.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Melo Bicchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.